Status:
WITHDRAWN
Validation of a Score That Predicts Residual Disease in Incidental Gallbladder Cancer
Lead Sponsor:
Emilio Ramos
Conditions:
Gallbladder Neoplasm Malignant Primary
Eligibility:
All Genders
Brief Summary
An incidental gallbladder carcinoma is detected in approximately 0.2% of the cholecystectomy specimens removed for presumed benign disease. In patients that meet specific criteria, a surgical re-opera...
Detailed Description
* Sample size: 30 (minimum). * Statistical analysis: populations will be compared with chi-square test or Fisher's exact test (categorical variables) and Student's t test or Mann-Whitney U test (conti...
Eligibility Criteria
Inclusion
- All consecutive patients with a diagnosis of incidental gallbladder cancer requesting therapeutic evaluation in the participating hospital centers.
Exclusion
- All patients with non-incidental gallbladder cancer.
- All patients with incomplete or deficient data collection.
- Patients without a signed informed consent.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04321577
Start Date
March 1 2020
End Date
April 1 2021
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907